These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 6177820)

  • 1. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
    Lachmann PJ; Pangburn MK; Oldroyd RG
    J Exp Med; 1982 Jul; 156(1):205-16. PubMed ID: 6177820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of three different fragments of bound C3 with purified factor I or serum. II. Location of binding sites in the C3 fragments for factors B and H, complement receptors, and bovine conglutinin.
    Ross GD; Newman SL; Lambris JD; Devery-Pocius JE; Cain JA; Lachmann PJ
    J Exp Med; 1983 Aug; 158(2):334-52. PubMed ID: 6224880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of monoclonal anti-C3 antibodies to characterise the fragments of C3 that are found on erythrocytes.
    Lachmann PJ; Voak D; Oldroyd RG; Downie DM; Bevan PC
    Vox Sang; 1983; 45(5):367-72. PubMed ID: 6605620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of the C3g component of the alpha 2D fragment of human C3.
    Chaplin H; Monroe MC; Lachmann PJ
    Clin Exp Immunol; 1983 Mar; 51(3):639-46. PubMed ID: 6602022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies against complement 3 neoantigens for detection of immune complexes and complement activation. Relationship between immune complex levels, state of C3, and numbers of receptors for C3b.
    Aguado MT; Lambris JD; Tsokos GC; Burger R; Bitter-Suermann D; Tamerius JD; Dixon FJ; Theofilopoulos AN
    J Clin Invest; 1985 Oct; 76(4):1418-26. PubMed ID: 2932466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 receptors on human lymphocyte subsets and recruitment of ADCC effector cells by C3 fragments.
    Wåhlin B; Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Immunol; 1983 Jun; 130(6):2831-6. PubMed ID: 6222118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bovine conglutinin binds to an oligosaccharide determinant presented by iC3b, but not by C3, C3b or C3c.
    Laursen SB; Thiel S; Teisner B; Holmskov U; Wang Y; Sim RB; Jensenius JC
    Immunology; 1994 Apr; 81(4):648-54. PubMed ID: 7518801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG; Melamed J; Arnaout MA
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
    Tamerius JD; Pangburn MK; Müller-Eberhard HJ
    J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody MoAb bH6 reacting with a neoepitope of human C3 expressed on C3b, iC3b, and C3c.
    Garred P; Mollnes TE; Lea T; Fischer E
    Scand J Immunol; 1988 Mar; 27(3):319-27. PubMed ID: 2451273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antigenic and molecular alterations of C3 in the fluid phase during an immune reaction in normal human serum. Demonstration of a new conversion product, C3x.
    Spitzer RE; Stitzel AE; Pauling VL; Davis NC; West CD
    J Exp Med; 1971 Sep; 134(3 Pt 1):656-80. PubMed ID: 15776568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
    Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
    Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a C3bi-specific membrane complement receptor that is expressed on lymphocytes, monocytes, neutrophils, and erythrocytes.
    Ross GD; Lambris JD
    J Exp Med; 1982 Jan; 155(1):96-110. PubMed ID: 6915077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of target cell-bound C3bi and C3d with human lymphocyte receptors. Enhancement of antibody-mediated cellular cytotoxicity.
    Perlmann H; Perlmann P; Schreiber RD; Müller-Eberhard HJ
    J Exp Med; 1981 Jun; 153(6):1592-603. PubMed ID: 7252421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial characterization of physiologically generated C3 components expressing C3d but not C3c epitopes.
    Siersted HC; Jensenius JC; Svehag SE; Brandslund I
    J Clin Lab Immunol; 1983 Dec; 12(4):201-8. PubMed ID: 6198522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of fibronectin with complement component C3.
    Hautanen A; Keski-Oja J
    Scand J Immunol; 1983 Mar; 17(3):225-30. PubMed ID: 6402811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three rat monoclonal antibodies to human C3.
    Lachmann PJ; Oldroyd RG; Milstein C; Wright BW
    Immunology; 1980 Nov; 41(3):503-15. PubMed ID: 6161872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of phagocytosis of complement C3- or immunoglobulin G-coated particles and of C3bi binding by monoclonal antibodies to a monocyte-granulocyte membrane glycoprotein (Mol).
    Arnaout MA; Todd RF; Dana N; Melamed J; Schlossman SF; Colten HR
    J Clin Invest; 1983 Jul; 72(1):171-9. PubMed ID: 6874946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity of three anti-complement factor 3 monoclonal antibodies.
    Henwick S; Hetherington SV; Hostetter MK
    J Immunol Methods; 1992 Aug; 153(1-2):173-84. PubMed ID: 1517587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.